PUMA BIOTECHNOLOGY, INC. (PBYI) Operating margin 2017–2025
PUMA BIOTECHNOLOGY, INC. (PBYI) operating margin by fiscal year — reported operating income divided by reported revenue.
16.3%FY2025 · since FY2017: -1056.1% → 16.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 16.3% | +2.9 pp |
| FY2024 | 13.4% | -0.4 pp |
| FY2023 | 13.9% | +3.4 pp |
| FY2022 | 10.4% | +9.9 pp |
| FY2021 | 0.5% | +14.0 pp |
| FY2020 | -13.5% | +0.8 pp |
| FY2019 | -14.3% | +23.4 pp |
| FY2018 | -37.7% | +1018.4 pp |
| FY2017 | -1056.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice